Page last updated: 2024-10-27

berotek and Myocardial Ischemia

berotek has been researched along with Myocardial Ischemia in 2 studies

Fenoterol: A synthetic adrenergic beta-2 agonist that is used as a bronchodilator and tocolytic.
fenoterol : A member of the class resorcinols that is 5-(1-hydroxyethyl)benzene-1,3-diol in which one of the methyl hydrogens is replaced by a 1-(4-hydroxyphenyl)propan-2-amino group. A beta2-adrenergic agonist, it is used (as the hydrobromide salt) as a bronchodilator in the management of reversible airway obstruction.

Myocardial Ischemia: A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zanoni, LZ1
Palhares, DB1
Consolo, LC1
Ahmet, I1
Lakatta, EG1
Talan, MI1

Trials

1 trial available for berotek and Myocardial Ischemia

ArticleYear
Myocardial ischemia induced by nebulized fenoterol for severe childhood asthma.
    Indian pediatrics, 2005, Volume: 42, Issue:10

    Topics: Administration, Inhalation; Asthma; Bronchodilator Agents; Child; Child, Preschool; Female; Fenotero

2005

Other Studies

1 other study available for berotek and Myocardial Ischemia

ArticleYear
Pharmacological stimulation of beta2-adrenergic receptors (beta2AR) enhances therapeutic effectiveness of beta1AR blockade in rodent dilated ischemic cardiomyopathy.
    Heart failure reviews, 2005, Volume: 10, Issue:4

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Anta

2005